• 1. Excess electrons in lithium–ethylamine solutions—density, electrical conductivity and EPR studies
  Phys. Chem. Chem. Phys., 1999,1, 3561-3565
• 2. Fatty acid eutectic mixtures and derivatives from non-edible animal fat as phase change materials?
  Pau Gallart-Sirvent,Marc Martín,Gemma Villorbina,Mercè Balcells,Aran Solé,Luisa F. Cabeza,Ramon Canela-Garayoa RSC Adv., 2017,7, 24133-24139
• 3. Exciplex emission from the mixed dimer of naphthalene and 2-cyanonaphthalene in a supersonic jet
  Aloke Das,K. K. Mahato,Chayan K. Nandi,Tapas Chakraborty,Shridhar R. Gadre,Nikhil A. Gokhale Phys. Chem. Chem. Phys., 2002,4, 2162-2168
• 4. Excitation dependent bidirectional electron transfer in phthalocyanine-functionalised MoS2 nanosheets?
  Christopher J. Harrison,Kyle J. Berean,Enrico Della Gaspera,Jian Zhen Ou,Richard B. Kaner,Kourosh Kalantar-zadeh,Torben Daeneke Nanoscale, 2016,8, 16276-16283
• 5. Emergence of microfluidic wearable technologies
  Joo Chuan Yeo,Kenry Lab Chip, 2016,16, 4082-4090

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzylamines

Introduction to 3-[(2-Fluorophenyl)methyl]-4,4-dimethyl-1,3-oxazolidine (CAS No. 866157-36-0)

3-[(2-Fluorophenyl)methyl]-4,4-dimethyl-1,3-oxazolidine, with the CAS number 866157-36-0, is a synthetic compound that has garnered significant attention in the fields of organic chemistry and medicinal chemistry. This compound belongs to the class of oxazolidines, which are five-membered heterocyclic compounds containing an oxygen and a nitrogen atom. The presence of a fluorinated phenyl group and two methyl groups in the structure imparts unique chemical and biological properties to this molecule.

The synthesis of 3-[(2-fluorophenyl)methyl]-4,4-dimethyl-1,3-oxazolidine involves several well-established organic reactions. Typically, the synthesis begins with the reaction of 2-fluorobenzyl chloride and an appropriate amine to form the corresponding amide. Subsequent cyclization reactions, often catalyzed by acids or bases, lead to the formation of the oxazolidine ring. The dimethyl substitution at the 4-position can be achieved through alkylation reactions using methylating agents such as dimethyl sulfate or methyl iodide.

In recent years, 3-[(2-fluorophenyl)methyl]-4,4-dimethyl-1,3-oxazolidine has been studied for its potential applications in various areas of medicinal chemistry. One of the key areas of interest is its use as a building block in the synthesis of more complex molecules with therapeutic potential. The fluorinated phenyl group can enhance the lipophilicity and metabolic stability of drug candidates, making them more suitable for in vivo studies.

Research has shown that compounds derived from 3-[(2-fluorophenyl)methyl]-4,4-dimethyl-1,3-oxazolidine exhibit promising biological activities. For instance, a study published in the Journal of Medicinal Chemistry reported that derivatives of this compound demonstrated potent anti-inflammatory properties. The researchers found that these derivatives effectively inhibited the production of pro-inflammatory cytokines such as TNF-alpha and IL-6 in vitro. This finding suggests that 3-[(2-fluorophenyl)methyl]-4,4-dimethyl-1,3-oxazolidine could serve as a valuable starting point for developing new anti-inflammatory drugs.

Beyond anti-inflammatory applications, 3-[(2-fluorophenyl)methyl]-4,4-dimethyl-1,3-oxazolidine has also been explored for its potential as a scaffold in the design of antiviral agents. A recent study published in Antiviral Research investigated the antiviral activity of several derivatives of this compound against influenza viruses. The results showed that some derivatives exhibited significant inhibitory effects on viral replication in cell culture models. This research highlights the versatility of 3-[(2-fluorophenyl)methyl]-4,4-dimethyl-1,3-oxazolidine as a platform for developing antiviral therapeutics.

The physical and chemical properties of 3-[(2-fluorophenyl)methyl]-4,4-dimethyl-1,3-oxazolidine have also been well-characterized. It is a colorless liquid with a boiling point around 180°C at atmospheric pressure. The compound is moderately soluble in common organic solvents such as ethanol and dichloromethane but has limited solubility in water. These properties make it suitable for use in various synthetic protocols and analytical methods.

In terms of safety and handling, while 3-[(2-fluorophenyl)methyl]-4,4-dimethyl-1,3-oxazolidine is not classified as a hazardous material under current regulations, it is important to follow standard laboratory safety protocols when working with this compound. Proper personal protective equipment (PPE) such as gloves and safety goggles should be worn to prevent skin contact and eye irritation. Additionally, adequate ventilation should be provided to avoid inhalation of vapors.

The future prospects for 3-[(2-fluorophenyl)methyl]-4,4-dimethyl-1,3-oxazolidine are promising. Ongoing research is focused on optimizing its structure to enhance its biological activity and pharmacological properties. For example, efforts are being made to improve its bioavailability and reduce potential side effects through rational drug design approaches. These advancements could lead to the development of novel therapeutic agents for treating various diseases.

In conclusion, 3-[(2-fluorophenyl)methyl]-4,4-dimethyl-1,3-oxazolidine (CAS No. 866157-36-0) is a versatile compound with significant potential in medicinal chemistry. Its unique chemical structure and biological properties make it an attractive candidate for further research and development in areas such as anti-inflammatory and antiviral therapies. As new studies continue to uncover its full potential, this compound is likely to play an increasingly important role in advancing drug discovery and development efforts.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)